The use of MR imaging in treatment planning for patients with rectal carcinoma: Have you checked the "distance"

Radiology

Volumn 268, Issue 2, 2013, Pages 330-334

  Nougaret, Stephanie ^a   Reinhold, Caroline ^b   Mikhael, Hisham W ^b   Rouanet, Philippe ^c   Bibeau, Frédéric ^d   Brown, Gina ^e  

^a HÔPITAL SAINT ELOI   (France)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c Departments of Surgery   (France)

^d CENTRE VAL D AURELLE   (France)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SCOPOLAMINE BUTYL BROMIDE;

ANUS SPHINCTER; ARTICLE; ARTIFACT REDUCTION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; CIRCUMFERENTIAL RESECTION MARGIN; CLINICAL ASSESSMENT TOOL; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; EXTRAMURAL VASCULAR INVASION; FASCIA; GENETIC SUSCEPTIBILITY; HUMAN; LYMPH VESSEL METASTASIS; MESORECTAL FASCIA; MUSCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGICAL PARAMETERS; PATIENT CODING; PATIENT POSITIONING; PELVIS FLOOR; PERSONALIZED MEDICINE; PREOPERATIVE CARE; PRIORITY JOURNAL; PUBORECTAL MUSCLE; RADIOLOGICAL PARAMETERS; RECTUM CARCINOMA; RISK ASSESSMENT; SURGICAL ANATOMY; SURGICAL TECHNIQUE; TRANSITIONAL SKIN TUMOR DISTANCE; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR INVASION; TUMOR LOCALIZATION;

CLINICAL PROTOCOLS; CONTRAST MEDIA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT CARE PLANNING; PATIENT SELECTION; PROGNOSIS; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84880682491     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13121361     Document Type: Article

References (68)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60(5): 277-300.
2. Maurer CA, Renzulli P, Kull C, et al. The impact of the introduction of total mesorectal excision on local recurrence rate and Figure 17 Figure 17: Summary of the "DISTANCE" mnemonic device. survival in rectal cancer: Long-term results. Ann Surg Oncol 2011;18(7):1899-1906.
3. Salerno G, Daniels I, Heald RJ, Brown G, Moran BJ. Management and imaging of low rectal carcinoma. Surg Oncol 2004;13(2): 55-61.
4. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355(11): 1114-1123.
5. Pedersen BG, Blomqvist L, Brown G, Fenger-Grøn M, Moran B, Laurberg S. Postgraduate multidisciplinary development program: Impact on the interpretation of pelvic MRI in patients with rectal cancer-A clinical audit in West Denmark. Dis Colon Rectum 2011; 54(3):328-334.
6. Taylor F, Mangat N, Swift IR, Brown G. Proforma-based reporting in rectal cancer. Cancer Imaging 2010;10(Spec no A):S142-S150.
7. Slater A, Halligan S, Taylor SA, Marshall M. Distance between the rectal wall and mesorectal fascia measured by MRI: Effect of rectal distension and implications for preoperative prediction of a tumour-free circumferential resection margin. Clin Radiol 2006; 61(1):65-70.
8. Wolff BG, Fleshman JW, Beck DE, Pemberton JH, Wexner SD. The ASCRS textbook of colon and rectal surgery. New York, NY: Springer, 2006.
9. Brown G, Richards CJ, Newcombe RG, et al. Rectal carcinoma: Thin-section MR imaging for staging in 28 patients. Radiology 1999; 211(1):215-222.
10. MERCURY Study Group, Shihab OC, Taylor F, et al. Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Br J Surg 2011; 98(12):1798-1804.
11. Okizuka H, Sugimura K, Yoshizako T, Kaji Y, Wada A. Rectal carcinoma: Prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging. J Magn Reson Imaging 1996;6(3): 465-471.
12. Vliegen RF, Beets GL, von Meyenfeldt MF, et al. Rectal cancer: MR imaging in local staging-is gadolinium-based contrast material helpful? Radiology 2005;234(1):179-188.
13. Beets-Tan RG. MRI in rectal cancer: The T stage and circumferential resection margin. Colorectal Dis 2003;5(5):392-395.
14. Brown G, Daniels IR. Preoperative staging of rectal cancer: The MERCURY research project. Recent Results Cancer Res 2005;165: 58-74.
15. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357(9255):497-504.
16. Merkel S, Mansmann U, Papadopoulos T, Wittekind C, Hohenberger W, Hermanek P. The prognostic inhomogeneity of colorectal carcinomas stage III: A proposal for subdivision of stage III. Cancer 2001;92(11):2754-2759.
17. Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001;16(5): 298-304.
18. MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY study. Radiology 2007;243(1): 132-139.
19. Pedersen BG, Moran B, Brown G, Blomqvist L, Fenger-Grøn M, Laurberg S. Reproducibility of depth of extramural tumor spread and distance to circumferential resection margin at rectal MRI: Enhancement of clinical guidelines for neoadjuvant therapy. AJR Am J Roentgenol 2011;197(6):1360-1366.
20. Kaur H, Choi H, You YN, et al. MR imaging for preoperative evaluation of primary rectal cancer: Practical considerations. Radio-Graphics 2012;32(2):389-409.
21. Smith N, Brown G. Preoperative staging of rectal cancer. Acta Oncol 2008;47(1):20-31.
22. Nagtegaal ID, van de Velde CJ, Marijnen CA, et al. Low rectal cancer: A call for a change of approach in abdominoperineal resection. J Clin Oncol 2005;23(36):9257-9264.
23. Chamlou R, Parc Y, Simon T, et al. Long-term results of intersphincteric resection for low rectal cancer. Ann Surg 2007;246(6):916-921; discussion 921-922.
24. Gerard JP, Chapet O, Nemoz C, et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The lyon R96-02 randomized trial. J Clin Oncol 2004;22(12):2404-2409.
25. Kao PS, Chang SC, Wang LW, et al. The impact of preoperative chemoradiotherapy on advanced low rectal cancer. J Surg Oncol 2010;102(7):771-777.
26. Weiser MR, Quah HM, Shia J, et al. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg 2009; 249(2):236-242.
27. Rouanet P, Saint-Aubert B, Lemanski C, et al. Restorative and nonrestorative surgery for low rectal cancer after high-dose radiation: Long-term oncologic and functional results. Dis Colon Rectum 2002;45(3):305-313; discussion 313-315.
28. Shihab OC, How P, West N, et al. Can a novel MRI staging system for low rectal cancer aid surgical planning? Dis Colon Rectum 2011; 54(10):1260-1264.
29. Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G. MRI staging of low rectal cancer. Eur Radiol 2009;19(3):643-650.
30. Holm T, Ljung A, Häggmark T, Jurell G, Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 2007;94(2):232-238.
31. West NP, Anderin C, Smith KJ, Holm T, Quirke P; European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg 2010;97(4):588-599.
32. West NP, Finan PJ, Anderin C, Lindholm J, Holm T, Quirke P. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 2008;26(21):3517-3522.
33. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatialresolution MR imaging with histopathologic comparison. Radiology 2003;227(2):371-377.
34. Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. High-resolution MR imaging for nodal staging in rectal cancer: Are there any criteria in addition to the size? Eur J Radiol 2004;52(1):78-83.
35. Koh DM, George C, Temple L, et al. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: Findings in pathologically matched mesorectal lymph nodes. AJR Am J Roentgenol 2010;194(6): W505-W513.
36. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2(8514): 996-999.
37. Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89(3):327-334.
38. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344(8924):707-711.
39. Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum 1991;34(9):798-804.
40. Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008;95(2):229-236.
41. Betge J, Pollheimer MJ, Lindtner RA, et al. Intramural and extramural vascular invasion in colorectal cancer: Prognostic significance and quality of pathology reporting. Cancer 2012;118(3):628-638.
42. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90(3):355-364.
43. Madoff RD. Chemoradiotherapy for rectal cancer-when, why, and how? N Engl J Med 2004;351(17):1790-1792.
44. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731-1740.
45. Taylor FG, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: A prospective, multicenter, European study. Ann Surg 2011;253(4):711-719.
46. Chen CC, Lee RC, Lin JK, Wang LW, Yang SH. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum 2005;48(4): 722-728.
47. Kuo LJ, Chern MC, Tsou MH, et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 2005;48(1):23-28.
48. Kim SH, Lee JM, Hong SH, et al. Locally advanced rectal cancer: Added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo-and radiation therapy. Radiology 2009;253(1):116-125.
49. Sun YS, Zhang XP, Tang L, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: Preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010; 254(1):170-178.
50. Lambregts DM, Vandecaveye V, Barbaro B, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: A multicenter study. Ann Surg Oncol 2011;18(8): 2224-2231.
51. Kim SH, Lee JY, Lee JM, Han JK, Choi BI. Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol 2011;21(5):987-995.
52. Lambrecht M, Vandecaveye V, De Keyzer F, et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: Preliminary results. Int J Radiat Oncol Biol Phys 2012;82(2):863-870.
53. Patel UB, Taylor F, Blomqvist L, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011;29(28):3753-3760.
54. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997;12(1):19-23.
55. Yeo SG, Kim DY, Kim TH, et al. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2010;78(1):164-171.
56. Kim YC, Lim JS, Keum KC, et al. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging 2011;34(3):570-576.
57. Kang JH, Kim YC, Kim H, et al. Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: The impact of the volume reduction ratio on the prediction of pathologic complete response. Int J Radiat Oncol Biol Phys 2010;76(4):1018-1025.
58. Curvo-Semedo L, Lambregts DM, Maas M, et al. Rectal cancer: Assessment of complete response to preoperative combined radiation therapy with chemotherapy-conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 2011;260(3):734-743.
59. Barbaro B, Fiorucci C, Tebala C, et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 2009;250(3):730-739.
60. Torkzad MR, Lindholm J, Martling A, Cedermark B, Glimelius B, Blomqvist L. MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry. Eur Radiol 2007; 17(6):1566-1573.
61. Nougaret S, Rouanet P, Molinari N, et al. MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology 2012;263(2): 409-418.
62. Reerink O, Verschueren RC, Szabo BG, Hospers GA, Mulder NH. A favourable pathological stage after neoadjuvant radiochemotherapy in patients with initially irresectable rectal cancer correlates with a favourable prognosis. Eur J Cancer 2003; 39(2):192-195.
63. Engelen SM, Beets-Tan RG, Lahaye MJ, Kessels AG, Beets GL. Location of involved mesorectal and extramesorectal lymph nodes in patients with primary rectal cancer: Preoperative assessment with MR imaging. Eur J Surg Oncol 2008;34(7):776-781.
64. Koh DM, Chau I, Tait D, Wotherspoon A, Cunningham D, Brown G. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2008;71(2):456-461.
65. Lahaye MJ, Beets GL, Engelen SM, et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? Radiology 2009;252(1): 81-91.
66. Koh DM, Brown G, Temple L, et al. Rectal cancer: Mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings-initial observations. Radiology 2004; 231(1):91-99.
67. Vliegen RF, Beets GL, Lammering G, et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: Accuracy of MR imaging for prediction. Radiology 2008; 246(2):454-462.
68. Salerno G, Daniels IR, Moran BJ, Wotherspoon A, Brown G. Clarifying margins in the multidisciplinary management of rectal cancer: The MERCURY experience. Clin Radiol 2006; 61(11):916-923.